Abstract:Abstract: Objective To observe the effect of PRT060318 (PRT318), an inhibitor of spleen tyrosine kinase (Syk), on human platelet aggregation and Syk phosphorylation in vitro. Methods The effect of PRT318 on platelet aggregation induced by collagen, adenosine diphosphate (ADP) and arachidonic acid (AA) was measured by turbidimetry. The phosphorylation of Syk525/6 was detected by Western blot. Results The Syk-specific inhibitor PRT318 suppressed collagen-induced platelet aggregation, while it did not have significantly inhibitory effect on ADP- or AA-induced platelet aggregation. The present data showed that PRT318 promoted the phosphorylation of Syk525/6 in collagen-induced platelets. PP2, tyrosine protein kinase (Src) inhibitor, inhibited collagen-induced platelet aggregation and decreased the level of Syk525/6 phosphorylation induced by collagen. PP2 also blocked PRT318-enhanced Syk525/6 phosphorylation in collagen-treated platelets. Conclusions PRT318 significantly inhibits collagen-induced platelet aggregation and promotes collagen-induced phosphorylation of Syk525/6 locating in the downstream of glycoprotein VI (GPVI) signal pathway, suggesting that PRT318 may inhibit platelet activation through regulating Syk525/6 phosphorylation.